ملاتونین ممکن است اثرات نامطلوبی بر کوفتگی عضلانی تاخیری داشته باشد

نوع مقاله: مقاله پژوهشی

نویسندگان

1 استاد دانشکده علوم ورزشی، دانشگاه فردوسی مشهد، مشهد، ایران

2 دانشجوی کارشناسی ارشد بیوشیمی، دانشکده علوم، دانشگاه فردوسی مشهد، مشهد، ایران

چکیده

زمینه و هدف: ملاتونین هورمونی با خواص فیزیولوژیک متنوع از جمله خواص ضددرد و ضدالتهاب می ­باشد و گزارش­ های ناهمسویی از اثر آن بر عملکرد ورزشی منتشر شده است. از این رو در تحقیق حاضر سعی شد تا اثر ملاتونین بر کوفتگی عضلانی بررسی شود­. روش تحقیق: در این تحقیق نیمه تجربی، 24 آزمودنی سالم مرد در یک طرح دوسو کور تصادفی، به دو گروه تجربی (تعداد 13 نفر، میانگین سنی 0/8±21/45 سال، قد 4/8±175 سانتی ­متر، وزن 6/9±74/4 کیلوگرم) و دارونما (تعداد 11 نفر، میانگین سنی 1/6±21/8 سال، قد 5/6±174 سانتی ­متر، وزن 11/2±67/18 کیلوگرم) تقسیم شدند. گروه تجربی، ملاتونین را به میزان 6 میلی ­گرم در روز به طور خوراکی به مدت 7 روز قبل از تمرین کوفتگی عضلانی، دریافت نمودند و گروه دارونما، کپسول­ های مشابه حاوی 6 میلی گرم لاکتوز دریافت کردند. کوفتگی عضلانی با استفاده از پروتکل پایین آمدن از پله در هر دو پا ایجاد شد. غلظت سرمی لاکتات دهیدروژناز (LDH)، کراتین­فسفوکیناز (CPK)، ظرفیت آنتی ­اکسیدانی تام و نیز مقیاس آنالوگ بصری درد و درد فشاری در زمان­ های 7 روز قبل، 24، 48 و 72 ساعت پس از پروتکل ایجاد کوفتگی، مورد اندازه ­گیری قرار گرفتند. برای بررسی تاثیر ملاتونین، از آزمون تحلیل واریانس با اندازه­ گیری مکرر و آزمون تعقیبی بونفرونی استفاده شد و سطح معنی داری 0/05>p منظور گردید. یافته‌ها: تنها افزایش معنی­ داری (0/01>p) در غلظت سرمی CPK گروه دارونما نسبت به گروه تجربی در 24 ساعت بعد از ایجاد کوفتگی عضلانی نسبت به پیش ­آزمون وجود داشت و شدت مقیاس آنالوگ بصری درد و درد فشاری در هر یک از مراحل، به طور معنی ­داری در گروه تجربی نسبت به گروه دارونما بالاتر بود (0/05<p). نتیجه ­گیری: نتایج تحقیق دال بر عدم تاثیر ملاتونین بر شاخص­های بیوشیمیایی التهاب، درد ادراکی و درد فشاری است و بنظر می ­رسد مصرف خوراکی آن با دوز 6 روز/ میلی­گرم در طول 7 روز، موجب افزایش درد کوفتگی عضلانی تاخیری ­شود.

کلیدواژه‌ها


عنوان مقاله [English]

Melatonin may have detrimental effects on the delayed-0nset muscle soreness

نویسندگان [English]

  • Abbas Meamarbashi 1
  • Fatemeh Meamarbashi 2
1 Professor at the Faculty of Sport Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
2 MSc student in Biochemistry, Ferdowsi University of Mashhad, Mashhad, Iran
چکیده [English]

Background and Aim: Melatonin is the hormone with different physiological effects, especially on analgesic and anti-inflammatory properties. contradictory reports published on the effect of melatonin on exercise performance. The present study attempt aimed to determine the effect of one-week oral administration of melatonin on delayed-onset muscle soreness (DOSM). Materials and Methods:  In this semi-experimental study, 24 healthy male subjects randomly divided into experimental and control groups. The experimental group received 6 mg per day melatonin, seven days before eccentric exercise and control group similarly received placebo. Muscle soreness produced in both feet during descending from a 50 cm bench. Serum Lactate dehydrogenase (LDH) and Creatine phosphokinase (CPK) concentration and total Antioxidant capacity (TAC) as well as the Visual Analogue Scale (VAS) of the pain and pressure pain, 7 days before eccentric protocol and 24, 48 and 72 hours after that were measured. Repeated measure analysis of variance (ANOVA) with Bonferroni comparison between two groups in each time was employed at pResults: CPK concentration was significantly increased in the placebo group when compared before and 24 hours after DOMS (P<0.001). Perceived pain and pressure pain, 7 days before protocol and 24 and 48 hours after protocol were significantly higher in the experimental group (P<0.01). Conclusion: The results of this study indicated no significant increase in the TAC and the same oral supplementation with melatonin consumption (6 mg per day for seven days) had no positive effect on TAC and the biochemical and clinical symptoms of the DOMS, therefore it seems melatonin increases pain in the DOMS.

کلیدواژه‌ها [English]

  • Melatonin
  • Delayed-onset muscle soreness
  • Total antioxidant capacity
  • Creatine phosphokinase (CPK)
  • Lactate dehydrogenase (LDH)
Alonso, M., Collado, P. S., & González-Gallego, J. (2006). Melatonin inhibits the expression of the inducible isoform of
nitric oxide synthase and nuclear factor kappa B activation in rat skeletal muscle. Journal of Pineal Research, 41(1), 8-14.
Armstrong, R. B. (1984). Mechanisms of exercise-induced delayed onset muscular soreness: a brief review. Medicine
and Science in Sports and Exercise, 16(6), 529-538.
Atkinson, G., Drust, B., Reilly, T., & Waterhouse, J. (2003). The Relevance of Melatonin to Sports Medicine and Science.
Sports Medicine, 33(11), 809-831.
Bijsterbosch, M. K., Duursma, A. M., Smit, M. J., Bos, O. J., Bouma, J. M., & Gruber, M. (1985). Several dehydrogenases and kinases compete for endocytosis from plasma by rat tissues. Biochemical Journal, 229(2), 409-417.
Bonnefont-Rousselot, D., & Collin, F. (2010). Melatonin: Action as antioxidant and potential applications in human disease
and aging. Toxicology, 278(1), 55-67.
Brancaccio, P., Lippi, G., & Maffulli, N. (2010). Biochemical markers of muscular damage. Clinical Chemistry and
Laboratory Medicine, 48(6), 757-767.
Citera, G., Arias, M. A., Maldonado-Cocco, J. A., La, M. A., Rosemffet, M. G., Brusco, L. I., ... & Cardinalli, D. P. (2000).
The effect of melatonin in patients with fibromyalgia: a pilot study. Clinical Rheumatology, 19(1), 9-13.
Cleak, M. J., & Eston, R. G. (1992). Delayed onset muscle soreness: mechanisms and management. Journal of Sports
Sciences, 10(4), 325-341.
Escames, G., Ozturk, G., Baño-Otálora, B., Pozo, M. J., Madrid, J. A., Reiter, R. J., ... & Acuña Castroviejo, D. (2012).
Exercise and melatonin in humans: reciprocal benefits. Journal of Pineal Research, 52(1), 1-11.
Grzelak, A., & Bartosz, G. (2005). Melatonin does not affect total antioxidant capacity of blood plasma in vitro. Scandinavian Journal of Clinical and Laboratory Investigation, 65(1), 77-81.
Howatson, G., & van Someren, K. A. (2008). The Prevention and Treatment of Exercise-Induced Muscle Damage. Sports
Medicine, 38(6), 483-503.
Kim, J., & Lee, J. (2014). A review of nutritional intervention on delayed onset muscle soreness. Part I. Journal of Exercise
Rehabilitation, 10(6), 349–356.
Kozai, D., Ogawa, N., & Mori, Y. (2014). Redox Regulation of Transient Receptor Potential Channels. Antioxidants & Redox
Signaling, 21(6), 971-986.
Lau, W. Y., Blazevich, A. J., Newton, M. J., Wu, S. S. X., & Nosaka, K. (2015). Assessment of muscle pain induced by
elbow-flexor eccentric exercise. Journal of Athletic Training, 50(11), 1140-1148.
Lenn, J. O. N., Uhl, T., Mattacola, C., Boissonneault, G., Yates, J., Ibrahim, W., & Bruckner, G. (2002). The effects of fish
oil and isoflavones on delayed onset muscle soreness. Medicine & Science in Sports & Exercise, 34(10), 1605-1613.
Marseglia, L., D'Angelo, G., Manti, S., Aversa, S., Arrigo, T., Reiter, R., & Gitto, E. (2015). Analgesic, anxiolytic and
anaesthetic effects of melatonin: new potential uses in pediatrics. International Journal of Molecular Sciences, 16(1),
1209-1220.
McGinley, C., Shafat, A., & Donnelly, A. E. (2009). Does antioxidant vitamin supplementation protect against muscle
damage? Sports Medicine, 39(12), 1011-1032.
Meamarbashi, A. (2017). Herbs and natural supplements in the prevention and treatment of delayed-onset muscle
soreness. Avicenna Journal of Phytomedicine, 7(1), 16-26.
Meamarbashi, A., & Abedini, F. (2011). Preventive effects of purslane extract on delayed onset muscle soreness induced by
one session bench-stepping exercise. Isokinetics and Exercise Science, 19(3), 199-206.
Meamarbashi, A., & Rajabi, A. (2015). Preventive Effects of 10-Day Supplementation With Saffron and Indomethacin on
the Delayed-Onset Muscle Soreness. Clinical Journal of Sport Medicine, 25(2), 105-112.
Newham, D. J., Jones, D. A., & Edwards, R. H. T. (1983). Large delayed plasma creatine kinase changes after stepping
exercise. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine, 6(5), 380-385.
Peterson, J. M., Trappe, T. A., Mylona, E., White, F., Lambert, C. P., Evans, W. J., & Pizza, F. X. (2003). Ibuprofen and
acetaminophen: effect on muscle inflammation after eccentric exercise. Medicine and Science in Sports and Exercise, 35
(6), 892-896.
Reiter, R. J., & Helmut, S. (1996). Antioxidant actions of melatonin. Advances in Pharmacology, 38, 103-117.
Reiter, R. J., Mayo, J. C., Tan, D. X., Sainz, R. M., Alatorre-Jimenez, M., & Qin, L. (2016). Melatonin as an antioxidant:
under promises but over delivers. Journal of Pineal Research, 61(3), 253–278.
Reiter, R. J., Tan, D. x., Mayo, J. C., Sainz, R. M., Leon, J., & Czarnocki, Z. (2003). Melatonin as an antioxidant:
biochemical mechanisms and pathophysiological implications in humans. Acta Biochimica Polonica-English Edition, 50
(4), 1129-1146.
Retamoso, L. T., Junior, M. E. S., Lima, F. D., Busanello, G. L., Bresciani, G., Ribeiro, L. R., ... & Oliveira, M. S. (2016).
Increased xanthine oxidase-related ROS production and TRPV1 synthesis preceding DOMS post-eccentric exercise in
rats. Life sciences, 152, 52-59.
Ricciotti, E., & FitzGerald, G. A. (2011). Prostaglandins and Inflammation. Arteriosclerosis, Thrombosis, and Vascular
Biology, 31(5), 986-1000.
Schwane, J. A., Johnson, S. R., Vandenakker, C. B., & Armstrong, R. B. (1982). Delayed-onset muscular soreness and
plasma CPK and LDH activities after downhill running. Medicine and Science in Sports and Exercise, 15(1), 51-56.
Serfaty, M., Kennell-Webb, S., Warner, J., Blizard, R., & Raven, P. (2002). Double blind randomised placebo controlled
trial of low dose melatonin for sleep disorders in dementia. International Journal of Geriatric Psychiatry, 17(12), 1120-
1127.
Shavali, S., Ho, B., Govitrapong, P., Sawlom, S., Ajjimaporn, A Klongpanichapak, S., & Ebadi, M. (2005). Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of β-endorphin an
endogenous opioid. Brain Research Bulletin, 64(6), 471-479.
Smith, L. L. (1991). Acute inflammation: the underlying mechanism in delayed onset muscle soreness? Medicine and
Science in Sports and Exercise, 23(5), 542-551.
Steinbacher, P., & Eckl, P. (2015). Impact of Oxidative Stress on Exercising Skeletal Muscle. Biomolecules, 5(2),
356-377.
Tartibian, B., Maleki, B. H., & Abbasi, A. (2009). The effects of ingestion of omega-3 fatty acids on perceived pain and
e x te r na l s ym pt om s o f de l ay ed on se t m us cl e s o re n es s i n un tr a in ed me n. Clin ica l J our na l of
Spor t M edi cin e, 19( 2 ) , 1 15- 1 1 9.
Tidball, J. G. (2005). Inflammatory processes in muscle injury and repair. American Journal of Physiology - Regulatory,
Integrative and Comparative Physiology, 288(2), R345-R353.
Van der Heijden, K. B., Smits, M. G., Van Someren, E. J., Ridderinkhof, K. R., & Gunning, W. B. (2007). Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia. Journal of the American Academy of Child &
Adolescent Psychiatry, 46(2), 233-241.
Veneroso, C., Tuñón, M. J., González-Gallego, J., & Collado, P. S. (2009). Melatonin reduces cardiac inflammatory injury induced by acute exercise. Journal of Pineal Research, 47(2), 184-191.
Waldhauser, F., Waldhauser, M., Lieberman, H. R., Deng, M. H., Lynch, H. J., & Wurtman, R. J. (1984). Bioavailability of
Oral Melatonin in Humans. Neuroendocrinology, 39(4), 307-313.